• OPEN AN ACCOUNT
Indian Indices
Nifty
25,492.30 -17.40
(-0.07%)
Sensex
83,216.28 -94.73
( -0.11%)
Bank Nifty
57,876.80 322.55
( 0.56%)
Nifty IT
35,117.65 -219.95
( -0.62%)
Global Indices
Nasdaq
16.76 83.45
(0.18%)
Dow Jones
6,751.11 9.79
(0.15%)
Hang Seng
50,211.07 -672.61
(-1.32%)
Nikkei 225
9,688.02 -47.76
(-0.49%)
Forex
USD-INR
88.65 -0.03
(-0.04%)
EUR-INR
101.82 -0.15
(-0.14%)
GBP-INR
115.54 -0.38
(-0.33%)
JPY-INR
0.58 0.00
(-0.08%)

EQUITY - MARKET SCREENER

Shukra Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524632
INE551C01044
1.4350033
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
178.13
1793.99
EPS(TTM)
Face Value()
Div & Yield %
0.23
1
0.02
 

As on: Nov 07, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
40.97 0.80 622773 178.13
Stock Price Details
Open Price() 40.96
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 40.97
Today's Low () 40.96
52-Week High () 42.7
152-Week Low () 5.75
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.02
Eps 0.23
Book Value 1.4350033
Market Cap (.Cr) 1,793.99
Face Value 1
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE551C01044


News
Shukra Pharmaceuticals to declare Quarterly Results
Shukra Pharmaceuticals schedules EGM
Shukra Pharmaceuticals Ltd - Board Meeting Outcome for Revised Outcome Of The Meeting Of The Board Of Directors Held On Friday October 03 2025.
Shukra Pharmaceuticals Ltd - Voting Result Along With Scrutinizer Report Of 32Nd Annual General Meeting (AGM) Of The Company Held On September 30 2025.
Shukra Pharmaceuticals to discuss results
Shukra Pharmaceuticals to hold AGM
Shukra Pharmaceuticals Ltd - Corrigendum To The Notice Of 32ND Annual General Meeting And Annual Report (2024-25) Of The Company
Shukra Pharmaceuticals Ltd - Intimation Of Record Date For Final Dividend For Financial Year 2024-2025.
Shukra Pharmaceuticals Ltd - Intimation Of Book Closure And Record Date Pursuant To Regulation 42 Of SEBI Listing Regulations For Annual General Meeting Of The Company.
Shukra Pharmaceuticals Ltd - Announcement Under Regulation 30 Of SEBI (LODR)- Strategic PAN India Distribution Tie-Up
More
Corporate Details
Incoporation Year   : 1993
Chairman : Dakshesh Shah
Bussiness Group :
Registered Office
Shukra Pharmaceuticals Ltd
3 rd Floor Dev House,
Opp WIAA Office Judges Bungalo,
Ahmedabad,
Gujarat-380054
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-079-66522247/27498515
Fax:N.A.
Fax:91-22-66317458
E-Mail : info@shukrapharmaceuticals.com
URL : http://www.shukrapharmaceuticals.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
No Data Found...!
No Data Found...!
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi